Literature DB >> 15778374

Regulation of the murine Ddelta2 promoter by upstream stimulatory factor 1, Runx1, and c-Myb.

Juan Carabana1, Eric Ortigoza, Michael S Krangel.   

Abstract

Accessibility control of V(D)J recombination at Ag receptor loci depends on the coordinate activities of transcriptional enhancers and germline promoters. Recombination of murine Tcrd gene segments is known to be regulated, at least in part, by the Tcrd enhancer (Edelta) situated in the Jdelta2-Cdelta intron. However, there has been little characterization of promoters and other cis-acting elements that are activated by or collaborate with Edelta and that might function to regulate Tcrd gene recombination events. We now describe a strong promoter that is tightly associated with the murine Ddelta2 gene segment. EMSAs reveal that upstream stimulatory factor 1, Runx1, c-Myb, lymphoid enhancer binding factor 1, NF1, and E47 all interact with this promoter in vitro. Of these, upstream stimulatory factor 1, Runx1, and c-Myb appear necessary for full promoter activity in transiently transfected cells. Moreover, the same three factors were found to interact with the promoter in vivo by chromatin immunoprecipitation. We suggest that these factors play important roles as Edelta-dependent regulators of Ddelta2 accessibility in vivo. Consistent with the established roles of c-Myb and Runx factors in Edelta function, we detected low level, enhancer-independent activity of the Ddelta2 promoter in transient transfection experiments. We speculate that the Ddelta2 promoter may play a role as a weak, enhancer-independent regulator in vivo, and might contribute to residual Tcrd rearrangement in Edelta(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778374     DOI: 10.4049/jimmunol.174.7.4144

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  DNA double-strand breaks relieve USF-mediated repression of Dβ2 germline transcription in developing thymocytes.

Authors:  Jennifer L Stone; Ruth E McMillan; David A Skaar; Justin M Bradshaw; Randy L Jirtle; Michael L Sikes
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

2.  ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer.

Authors:  Jennifer A Mertz; Ryuji Kobayashi; Jaquelin P Dudley
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Orchestrating T-cell receptor α gene assembly through changes in chromatin structure and organization.

Authors:  Han-Yu Shih; Bingtao Hao; Michael S Krangel
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

4.  A barrier-type insulator forms a boundary between active and inactive chromatin at the murine TCRβ locus.

Authors:  Juan Carabana; Akiko Watanabe; Bingtao Hao; Michael S Krangel
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

5.  Long-distance regulation of fetal V(δ) gene segment TRDV4 by the Tcrd enhancer.

Authors:  Bingtao Hao; Michael S Krangel
Journal:  J Immunol       Date:  2011-07-22       Impact factor: 5.422

6.  Promoter activity 5' of Dbeta2 is coordinated by E47, Runx1, and GATA-3.

Authors:  Ruth E McMillan; Michael L Sikes
Journal:  Mol Immunol       Date:  2009-07-09       Impact factor: 4.407

7.  CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal elements.

Authors:  Berta N Vazquez; Teresa Laguna; Juan Carabana; Michael S Krangel; Pilar Lauzurica
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

8.  Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.

Authors:  Miyuki Matsuda; Kouichi Tamura; Hiromichi Wakui; Akinobu Maeda; Masato Ohsawa; Tomohiko Kanaoka; Kengo Azushima; Kazushi Uneda; Sona Haku; Yuko Tsurumi-Ikeya; Yoshiyuki Toya; Yohei Maeshima; Akio Yamashita; Satoshi Umemura
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

9.  A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets.

Authors:  Ruli Gao; Chunxia Cao; Min Zhang; Maria-Cecilia Lopez; Yuanqing Yan; Zirong Chen; Yoshitsugu Mitani; Li Zhang; Maria Zajac-Kaye; Bin Liu; Lizi Wu; Rolf Renne; Henry V Baker; Adel El-Naggar; Frederic J Kaye
Journal:  Oncotarget       Date:  2014-12-30

10.  Transcription factor site dependencies in human, mouse and rat genomes.

Authors:  Andrija Tomovic; Michael Stadler; Edward J Oakeley
Journal:  BMC Bioinformatics       Date:  2009-10-16       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.